OMC
ITOS

Oasis Management Company’s iTeos Therapeutics ITOS Stock Holding History

Oasis Management Company’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,000
Closed -$469K – 92
2022
Q4 		$469K Hold
24,000
– – 0.09% 71
2022
Q3 		$457K Hold
24,000
– – 0.08% 88
2022
Q2 		$494K Buy
+24,000
New +$570K 0.09% 89

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Oasis Management Company's ITOS Position: Q1 2023 in Review

Oasis Management Company sold out of iTeos Therapeutics (ITOS) in Q1 2023, closing a stake of 24,000 shares — an estimated $469K sold.

Oasis Management Company first reported a position in ITOS in Q2 2022 and held it in 3 quarters. The position peaked at $494K in Q2 2022. 153 funds tracked by Wall St. Rank hold ITOS as of Q1 2023.

  • Oasis Management Company reported no remaining iTeos Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 24,000 iTeos Therapeutics shares in Q1 2023, an estimated $469K.
  • Oasis Management Company first reported a position in iTeos Therapeutics in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's iTeos Therapeutics position peaked at $494K in Q2 2022.
  • 153 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.